Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition • 09-14 May 2026

Digital Poster

Spectroscopy and Spectroscopic Imaging: Neuro I

Back to the Program-at-a-Glance

Spectroscopy and Spectroscopic Imaging: Neuro I
Digital Poster
Contrast Mechanisms
Monday, 11 May 2026
Digital Posters Row C
14:45 - 15:40
Session Number: 362-04
No CME/CE Credit
This session focuses on quantitative MR spectroscopy (MRS) methods in the human brain, including metabolite measurement using semi-LASER, strategies for motion correction, and advanced processing techniques for robust and reproducible in-vivo brain metabolite quantification in research and clinical settings.
Skill Level: Intermediate

  Figure 362-04-001.  Quantitative Measurements of Metabolite R₁ρ and R₂ρ Relaxations in the Human Brain at 3 Tesla
Dinesh Deelchand, Silvia Mangia, Shalom Michaeli
University of Minnesota, Minneapolis, United States of America
Impact: Investigating R and R relaxation of metabolites to gain insight into their spin dynamics
  Figure 362-04-002.  Cross-vendor implementation and comparison of a 2D sLASER-rosette sequence for MRSI of the human brain
Emile Kadalie, Michel Lauzon, Chathura Kumaragamage, Mervyn Singh, Milton Camacho, Filomeno Cortese, Vicente Enguix, Neta Bar Am, Ashley Harris , Gregory Lodygensky, Jamie Near
Sunnybrook Research Institute, Toronto, Canada
Impact: This study demonstrates a cross-vendor implementation of a rosette sLASER MRSI sequence, achieving comparable metabolite quantification across Siemens and GE 3T systems - an essential step toward standardized, multi-site studies of brain metabolism using rapid non-Cartesian MRSI.
  Figure 362-04-003.  Detection of Cystathionine, GABA, Glutamate, and Glutamine in the Healthy Human Hippocampus at 3T
Justin Singer, Elena Ivleva, Kimberly Chan
University of Texas Southwestern Medical Center, Dallas, United States of America
Impact: This study utilized an optimized metabolite-cycling MEGA-editing scheme to achieve the non-invasive detection of Cyst, GABA, glutamate, and glutamine within the healthy human hippocampal subregions, which may serve as potential biomarkers for neurodegenerative and psychiatric disorders.

  Figure 362-04-004.  Investigating Diurnal Changes in Metabolite Ratios in the Human Brain Using 7T MRSI
Philipp Lazen, Sara Huskic, Ahmet Azgın, Sagar Acharya, Bernhard Strasser, Lukas Hingerl, Wolfgang Bogner, Gilbert Hangel, Karl Rössler
Medical University of Vienna, Vienna, Austria
Impact: This study provides baseline data on the variability of brain metabolites throughout the day, suggesting that diurnal effects are minor compared to regional and technical variability. It highlights the stability of 7T MRSI in frontal and parietal lobe.
  Figure 362-04-005.  Quantifying Cerebral Lactate with MRS: Detecting Hypoxia-Linked Metabolic Alterations
Atilla Gonenc, Eva-Maria Ratai, Eve Valera
Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Charlestown, United States of America
Impact: Advanced MRS such as HERCULES addresses a critical neuroimaging gap across psychiatric, neurological, and metabolic disorders by overcoming conventional MRS limitations and enabling lactate quantification.
  Figure 362-04-006.  Evidence-based denoising optimization for accurate GABA estimation by 14.1-tesla 13C-MRS
Kelley Swanberg, Iben Lundgaard, Joao M.N. Duarte
Lund University, Lund, Sweden
Impact: Spectral denoising methods like apodization (AD), singular value decomposition (SVD), and wavelet transformation (WT) may improve spectral signal-to-noise ratio (SNR), but their effects on metabolite quantification error are often less certain, demanding validation against broad practical use cases.
  Figure 362-04-007.  Real-Time Motion and B0 Correction in 3D ECCENTRIC MRSI with Deep Learning Reconstruction
Nutandev Bikkamane Jayadev, Paul Weiser, Andre van der Kouwe, Robert Frost, Yulin Chang, Antoine Klauser, Ovidiu Andronesi
Siemens Medical Solutions USA, Inc., Malvern, United States of America
Impact: Integrating GRAPPA-accelerated vNavs with 3D ECCENTRIC MRSI stabilizes motion and B0 in real time, preserving the spectral quality, while DeepER deep-learning reconstruction shortens computation, advancing high resolution whole brain metabolite imaging towards practical, efficient workflows.
  Figure 362-04-008.  Algorithmic Determination of Early Scan Stopping for GABA-edited MRS
Hanna Bugler, Roberto Souza, Ashley Harris
University of Calgary, Calgary, Canada
Impact: Shorter scan times improve participant compliance and reduce the likelihood of motion artifacts resulting in higher quality data for metabolite quantification. Retrospective analysis shows that GABA+-edited MRS scans can be reduced by ~50% on average without compromising quantification accuracy.
  Figure 362-04-009.  Metabolomic profiling of Serum, Urine, and Saliva reveals differential metabolic changes in Parkinson’s Disease using NMR
Sadhana Kumari, S Senthil Kumaran, Shivam Pandey, Roopa Rajan, Achal Srivastava
All India Institute of Medical Sciences, New Delhi, India
Impact: This study highlights non-invasive NMR metabolomics of serum, urine, and saliva as a promising tool to identify consistent metabolic fingerprints for Parkinson’s disease, enabling improved biomarker-based diagnosis and deeper mechanistic insights, independent of age of onset.
  Figure 362-04-010.  Quantitative and multivariate discrimination of healthy and tumor metabolite profiles acquired with in vivo MR spectroscopy
Rachel Goldberg, Candace Fleischer
Emory University, Atlanta, United States of America
Impact: Reference ranges of healthy brain metabolites at 7T were generated with bootstrapping. Clear differentiation between healthy ranges and glioma was evidenced by large Mahalanobis distances, demonstrating feasibility as a quantitative and multivariate metric to identify metabolic abnormality in glioma.
  Figure 362-04-011.  Exploring neurometabolic changes associated with chronic fatigue in Inflammatory Bowel Disease at 7T 1H MRS – 7T-FIB study
Lieke van Dongen, Jack van Asten, Evita Wiegers, Jannie Wijnen, Tom Scheenen, Marjolijn Duijvestein, Esther Aarts, Anja van der Kolk, Irene van Kalleveen
Radboud University Medical Center, Nijmegen, Netherlands
Impact: This study will provide new insights in the underlying neurometabolic changes associated with chronic fatigue in quiescent IBD-patients, allowing for more targeted treatment. It could also provide new insights for chronically fatigued patients diagnosed with other underlying medical conditions.
  Figure 362-04-012.  Optimizing brain 31P-MRS at 3T: A comparison of single-voxel localization methods
Alex Ensworth, Erin MacMillan, Cornelia Laule
University of British Columbia, Vancouver, Canada
Impact: Identifying the most reliable single-voxel 31P-MRS localization at 3T will help guide brain protocol standardization, improve spectral quality and motion robustness, and accelerate clinical and translational studies of cerebral energetics and membrane turnover.
  Figure 362-04-013.  Chronic and Acute Phenylalanine Exposure in Adults with Phenylketonuria: An In Vivo ¹H-MRS Study
Raphaela Muri, Maike Hoefemann, Vanessa Vallesi, Laura Winiger, Karin Zwygart, Roman Trepp, Regula Everts, Roland Kreis
Inselspital, University of Bern, Switzerland
Impact: This study demonstrates widespread cerebral metabolic alterations in adults with Phenylketonuria beyond phenylalanine (Phe) accumulation. Short-term Phe elevation alters glial osmolyte markers without relating to cognition. Findings confirm strong blood–brain Phe coupling highlighting ongoing cerebral susceptibility in treated PKU.
  Figure 362-04-014.  Towards a Foundation Model for Magnetic Resonance Spectroscopy
Wesna Simone Bulla de Araujo, Hanna Bugler, Ashley Harris , Roberto Souza, Letícia Rittner
University of Campinas, Campinas, Brazil
Impact: The foundation model decreases the need for large datasets in new MRS tasks, as core knowledge is already learned during pre-training. This facilitates broader research and supports clinical translation of MRS, since small datasets are commonly available in this field.
  Figure 362-04-015.  Subjective Well-Being and Anterior Cingulate Cortex Metabolites in Young Adults: A ¹H-MRS Study
LingYang Zeng, Wei Su, Qianwen Zhang, Jiaxiang xin, Xuan Li, Zhengqi Zhu, Kaihua Zhang
Shandong Normal University, Jinan, China
Impact: Increased NAA in the ACC may indicate low subjective well-being in young adults, while gender-related variations in Glu and Glx underscore the contribution of excitatory neurotransmission to everyday affective differences.
  Figure 362-04-016.  Quantification of lactate, glutathione, and GABA in metastatic lesions with MEGA-sLASER at 3 Tesla.
Andrei Manzhurtsev, Svenja Klinsing, Seyma Alcicek, Dennis Thomas, Anna-Luisa Luger, Ulrich Pilatus, Katharina Weber, Joachim Steinbach, Elke Hattingen, Pia Zeiner, Katharina Wenger
Goethe University, University Hospital Frankfurt, Institute of Neuroradiology and Cooperative Brain Imaging Center - CoBIC, Frankfurt am Main, Germany
Impact: MEGA-sLASER combined with qMRI enables accurate lactate, GABA, and GSH quantification in brain metastasis. The results indicate that Lac alterations in metastasis tissue have a distinct origin from the lactate invasively measured in CSF. Metastasis GABA and GSH are decreased.

Back to the Program-at-a-Glance

© 2026 International Society for Magnetic Resonance in Medicine